Ana Estevez

Ana Estevez


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
AEAna Estevez
Ana Estevez
SPS. Pritchard
S. Pritchard
KHK. Harper
K. Harper
JAJ.W. Aston
J.W. Aston
ALA. Lynch
A. Lynch
JEJ.S. Erlichman
J.S. Erlichman

3 October 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
AEAna Estevez
Ana Estevez
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
JTJohn F. Trentini
John F. Trentini
JOJames Olson
James Olson
GLGuangze Li
Guangze Li
Joseph  ErlichmanJoseph Erlichman
Joseph Erlichman
Cerium oxide (CeO2) nanoparticles (CeNPs) are potent antioxidants that are being explored as potential therapies for diseases in which oxidative stress plays an important pathological role. However, both beneficial and toxic effects of CeNPs have been reported, and the method of synthesis as well as physico-chemical, biological, and environmental factors can impact the ultimate biological effects of CeNPs. In the present study, we explored the effect of different ratios of citric acid (CA) and EDTA (CA/EDTA), which are used as stabilizers during synthesis of CeNPs, on the antioxidant enzyme-mimetic and biological activity of the CeNPs. We separated the CeNPs into supernatant and pellet fractions and used commercially available enzymatic assays to measure the catalase-, superoxide dismutase (SOD)-, and oxidase-mimetic activity of each fraction. We tested the effects of these CeNPs in a mouse hippocampal brain slice model of ischemia to induce oxidative stress where the fluorescence indicator SYTOX green was used to assess cell death. Our results demonstrate that CeNPs stabilized with various ratios of CA/EDTA display different enzyme-mimetic activities. CeNPs with intermediate CA/EDTA stabilization ratios demonstrated greater neuroprotection in ischemic mouse brain slices, and the neuroprotective activity resides in the pellet fraction of the CeNPs. The neuroprotective effects of CeNPs stabilized with equal proportions of CA/EDTA (50/50) were also demonstrated in two other models of ischemia/reperfusion in mice and rats. Thus, CeNPs merit further development as a neuroprotective therapy for use in diseases associated with oxidative stress in the nervous system.

1 January 2011 in ACS Symposium Series
Verified
Book Chapter
Closed access
AEAna Estevez
Ana Estevez
JEJ. S. Erlichman
J. S. Erlichman